"The
Report Amyotrophic Lateral Sclerosis Global Clinical Trials Review,
H2, 2016 provides information on pricing, market analysis, shares,
forecast, and company profiles for key industry participants. -
MarketResearchReports.biz"
GlobalData's clinical trial
report, Amyotrophic
Lateral Sclerosis
Global Clinical Trials Review, H2, 2016" provides an overview of
Amyotrophic Lateral Sclerosis clinical trials scenario. This report
provides top line data relating to the clinical trials on Amyotrophic
Lateral Sclerosis. Report includes an overview of trial numbers and
their average enrollment in top countries conducted across the globe.
The report offers coverage of disease clinical trials by region,
country (G7 & E7), phase, trial status, end points status and
sponsor type. Report also provides prominent drugs for in-progress
trials (based on number of ongoing trials). GlobalData Clinical Trial
Reports are generated using GlobalDatas proprietary database - Pharma
eTrack Clinical trials database. Clinical trials are collated from
80+ different clinical trial registries, conferences, journals, news
etc across the globe. Clinical trials database undergoes periodic
update by dynamic process.
The report enhances the
decision making capabilities and helps to create an effective counter
strategies to gain competitive advantage.
Download
Sample copy of this Report at :
http://www.marketresearchreports.biz/sample/sample/816372
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top
Five Countries Contributing to Clinical Trials in Europe 10
Top
Countries Contributing to Clinical Trials in North America 11
Top
Countries Contributing to Clinical Trials in Middle East and Africa
12
Top
Countries Contributing to Clinical Trials in Central and South
America 13
Clinical
Trials by G7 Countries: Proportion of Amyotrophic Lateral Sclerosis
to Central Nervous System Clinical Trials 14
Clinical
Trials by Phase in G7 Countries 15
Clinical
Trials in G7 Countries by Trial Status 16
Clinical
Trials by E7 Countries: Proportion of Amyotrophic Lateral Sclerosis
to Central Nervous System Clinical Trials 17
Clinical
Trials by Phase in E7 Countries 18
Clinical
Trials in E7 Countries by Trial Status 19
Clinical
Trials by Phase 20
In
Progress Trials by Phase 21
Clinical
Trials by Trial Status 22
Clinical
Trials by End Point Status 23
Subjects
Recruited Over a Period of Time 24
Clinical
Trials by Sponsor Type 25
Prominent
Sponsors 26
Top
Companies Participating in Amyotrophic Lateral Sclerosis Therapeutics
Clinical Trials 27
Prominent
Drugs 29
Latest
Clinical Trials News on Amyotrophic Lateral Sclerosis 30
Jul
20, 2016: The ALS Association and ALS Finding a Cure Announce Joint
Funding Support for Amylyx Clinical Trial of AMX0035 for the
Treatment of ALS 30
Jul
18, 2016: BrainStorm Announces Positive Top Line Results from the
U.S. Phase 2 Study of NurOwn in Patients with Amyotrophic Lateral
Sclerosis (ALS) 30
Jul
11, 2016: AB Science Announces The Publication In The Journal Of
Neuroinflammation Of Preclinical Data Showing Neuroprotective Effect
Of Masitinib In Amyotrophic Lateral Sclerosis 32
Clinical
Trial Profile Snapshots 33
Appendix
179
Abbreviations
179
Definitions
179
Research
Methodology 180
Secondary
Research 180
About
GlobalData 181
Contact
Us 181
Disclaimer
181
Source
182
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment